RCC Tcell receptors and related materials and methods of use

Details for Australian Patent Application No. 2009282886 (hide)

Owner The United States of America, as represented by the Secretary, Department of Health and Human Services

Inventors Wang, Qiong J.; Hanada, Kenichi; Yang, James C.

Agent Fisher Adams Kelly

Pub. Number AU-A-2009282886

PCT Pub. Number WO2010/022198

Priority 12/196,833 22.08.08 US

Filing date 20 August 2009

Wipo publication date 25 February 2010

International Classifications

C07K 14/705 (2006.01) Peptides having more than 20 amino acids

A61K 38/46 (2006.01) Medicinal preparations containing peptides

A61K 48/00 (2006.01) Medicinal preparations containing genetic material which is inserted into cells of the living body to treat genetic diseases

Event Publications

10 March 2011 PCT application entered the National Phase

  PCT publication WO2010/022198 Priority application(s): WO2010/022198

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2009282888-Prodrugs of methyl hydrogen fumarate, pharmaceutical compositions thereof, and methods of use

2009282884-[4-(5-aminomethyl-2-fluoro-phenyl)-pipe ridin1-yl]-[7-fluoro-1-(2-methoxy-ethyl)-4-trifl uoromethoxy-1H-indol-3-yl]-methanone as an inhibitor of mast cell tryptase